Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma by Patrick Born, David Fandrei, Song Yau Wang, Carmen Perez‐Fernandez, Luise Fischer, Jule Ussmann, Enrica Bach, Sandra Hoffmann, Klaus H. Metzeler, Marco Herling, Carmen Herling, Madlen Jentzsch, Andreas Boldt, Sabine Seiffert, Ronny Baber, Heike Weidner, Georg‐Nikolaus Franke, Timm Denecke, Osama Sabri, Uwe Platzbecker, Vladan Vucinic, Hans Jonas Meyer, Lars Kurch, Maximilian Merz

Get full text

Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study by Maximilian Merz, Anca‐Maria Albici, Bastian vonTresckow, Kristin Rathje, Roland Fenk, Tobias Holderried, Fabian Müller, Natalia Tovar, Aina Oliver‐Cáldes, Vladan Vucinic, Soraya Kharboutli, Ben‐Niklas Bärmann, Francis Ayuk, Uwe Platzbecker, Friedrich Stölzel, Nathalie Schub, Friederike Schmitz, David Fandrei, Patrick Born, Cyrus Khandanpour, Christine Hanoun, Keven Hörster, Marcel Teichert, Barbara Jeker, Michele Hoffmann, Nicolaus Kröger, Carlos Fernández de Larrea, Thomas Pabst, Nico Gagelmann

Get full text